Healthcare

Orly Pharma is a pharmaceutical wholesaler.

The capital infusion will be used by NMS as a recapitalization to support the firm's growth.

BCLP's David Schwartz: 'The FTC has invested heavily in understanding and tracking private equity dealmaking in healthcare, and I do not see those investments being discarded just because of a change in administration.'

RiverGlade Capital, InTandem Capital Partners and FFL Partners are among the firms looking to capitalize on infusion service investments.

Supreme Group is a platform of business and commercialization services to life science and healthcare companies.

Therakos provides ECP delivery systems for autologous immunomodulatory therapy.

Value creation will include M&A and a new management team, managing directors Olivier Lieven and Tobias Nordblom told PE Hub.

ForLife manufactures medical devices and aids with a core focus on stoma care.

Morgan Stanley, L Catterton and R F Investment Partners are among the firms making deals in the veterinary sector.

Cardinal Health agreed to take a majority stake in the gastroenterologist network, valuing it at $3.9bn.